On a top 10 list of things to do, getting your cholesterol level checked likely doesn't make the cut—but no matter your age, knowing your numbers can be a crucial factor in overall health.
Feb 2, 2023
0
6
A UCF College of Medicine researcher has identified for the first time a tiny liver protein that when disrupted can lead to the nation's top killer—cardiovascular disease—as well as fatty liver disease, a precursor to ...
Jun 10, 2016
0
81
A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.
Jun 10, 2019
0
74
It might be possible to prevent atherosclerosis by changing the appearance of macrophages, cells of the immune system that for example digest foreign substances. In her Ph.D. dissertation, Baoyan Ren examined several ways ...
Feb 8, 2018
0
3
Eating nuts every day could help control Type 2 diabetes and prevent its complications, according to new research from St. Michael's Hospital and the University of Toronto.
Jul 12, 2011
0
0
A new study highlights possible cardiovascular health advantages in individuals with a rare condition known as growth hormone receptor deficiency (GHRD), also called Laron syndrome.
Apr 26, 2024
0
108
Reducing glycated hemoglobin (HbA1c), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and body mass index (BMI) can improve life expectancy (LE) among people with type 2 diabetes (T2D), according ...
Apr 19, 2022
0
2
(HealthDay)—For patients with type 2 diabetes, during Ramadan, the greatest change among metabolic parameters is seen for glycemia, according to a study published online May 13 in the Journal of Diabetes Investigation.
May 20, 2015
0
10
Cholesterol-lowering statins were associated with lower risk for major cardiac events in some patients with preexisting ischemic heart disease but not in others, according to an article published online by JAMA Internal Medicine.
Jun 20, 2016
0
3
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, ...
May 26, 2011
1
0
